Bank of New York Mellon’s Telomir Pharmaceuticals TELO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.3K | Sell |
51,453
-39,900
| -44% | -$49.9K | ﹤0.01% | 4058 |
|
|
2025
Q1 | $295K | Buy |
91,353
+19,058
| +26% | +$61.6K | ﹤0.01% | 3690 |
|
|
2024
Q4 | $298K | Buy |
72,295
+20,931
| +41% | +$86.2K | ﹤0.01% | 3766 |
|
|
2024
Q3 | $330K | Buy |
51,364
+1,199
| +2% | +$7.7K | ﹤0.01% | 3710 |
|
|
2024
Q2 | $241K | Buy |
+50,165
| New | +$241K | ﹤0.01% | 3890 |
|